These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9821915)

  • 1. Botulinum A toxin in spinal cord injury.
    Schurch B
    Arch Phys Med Rehabil; 1998 Nov; 79(11):1481. PubMed ID: 9821915
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum-A toxin in the treatment of neurogenic bladder in children.
    Schulte-Baukloh H; Knispel HH; Michael T
    Pediatrics; 2002 Aug; 110(2 Pt 1):420-1. PubMed ID: 12165609
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
    Chen SF; Chang CH; Kuo HC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
    Deshpande AV; Sampang R; Smith GH
    ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity.
    Gutiérrez-Martín P; Vírseda-Chamorro M; Salinas Casado J; Gómez-Rodríguez A; Esteban-Fuertes M
    Actas Urol Esp; 2015 May; 39(4):217-21. PubMed ID: 25582926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
    Goessaert AS; Everaert KC
    Expert Rev Neurother; 2012 Jul; 12(7):763-75. PubMed ID: 22853784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial Comment to Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
    Truzzi JC
    Int J Urol; 2015 Dec; 22(12):1165-6. PubMed ID: 26768843
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
    Alvares RA; Silva JA; Barboza AL; Monteiro RT
    Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tips and Tricks in Intra-Detrusor Botulinum Toxin A (BoNTA) Injections.
    Corcos J; Biardeau X; Aharony S
    World J Urol; 2015 Jun; 33(6):899-901. PubMed ID: 26217823
    [No Abstract]   [Full Text] [Related]  

  • 11. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
    Cruz F; Nitti V
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial.
    Burki JR; Hamid R
    Spinal Cord; 2013 Sep; 51(9):725. PubMed ID: 23774129
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Opposing views T. B. Boone and I. Perkash J Urol 2009; 181: 1538-1540.
    Pannek J
    J Urol; 2010 Jan; 183(1):400-1; author reply 401-2. PubMed ID: 19932493
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to ‘Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial’.
    Krhut J; Samal V; Nemec D; Zvara P
    Spinal Cord; 2013 Sep; 51(9):726. PubMed ID: 23797569
    [No Abstract]   [Full Text] [Related]  

  • 15. Applicability of botulinum toxin type A in paediatric neurogenic bladder management.
    Scheepe JR; Blok BF; 't Hoen LA
    Curr Opin Urol; 2017 Jan; 27(1):14-19. PubMed ID: 27748667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
    Harris MA; Harding C; Fulford S; Whiteway J
    BJU Int; 2011 Apr; 107(7):1165; author reply 1165. PubMed ID: 21438980
    [No Abstract]   [Full Text] [Related]  

  • 17. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
    Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
    Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin. From poison to medical wonder.
    Mayo Clin Health Lett; 2006 Dec; 24(12):4-5. PubMed ID: 17310508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.